Alyeska Investment Group, L.P. Acquires New Stake in Guardian Pharmacy Services Inc
GRDN Stock | 24.28 0.66 2.65% |
About 56% of all Guardian Pharmacy's investors are looking to take a long position. The analysis of current outlook of investing in Guardian Pharmacy Services, suggests that some traders are interested regarding Guardian Pharmacy's prospects. Guardian Pharmacy's investing sentiment overview a quick insight into current market opportunities from investing in Guardian Pharmacy Services,. Many technical investors use Guardian Pharmacy stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Guardian |
Overview of Alyeskas Recent Transaction On September 30, 2024, Alyeska Investment Group, L.P. , a prominent hedge fund, marked a significant
Read at gurufocus.com
Guardian Pharmacy Fundamental Analysis
We analyze Guardian Pharmacy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardian Pharmacy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardian Pharmacy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Guardian Pharmacy is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Guardian Pharmacy Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Guardian Pharmacy stock to make a market-neutral strategy. Peer analysis of Guardian Pharmacy could also be used in its relative valuation, which is a method of valuing Guardian Pharmacy by comparing valuation metrics with similar companies.
Peers
Guardian Pharmacy Related Equities
VMD | Viemed Healthcare | 3.69 | ||||
NVNO | EnVVeno Medical | 1.93 | ||||
TFX | Teleflex Incorporated | 0.76 | ||||
VRRM | Verra Mobility | 0.51 | ||||
GOLD | Barrick Gold | 0.97 | ||||
PAL | Proficient Auto | 3.07 |
Check out Guardian Pharmacy Hype Analysis, Guardian Pharmacy Correlation and Guardian Pharmacy Performance. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.